Aggressive primary splenic CD5 positive/Cyclin D1 negative B-cell lymphoma in a patient with chronic hepatitis B virus infection

Author： Alagiozian-Angelova Victoria Xu Gang Peace David Gaitonde Sujata

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.47, Iss.8, 2008-01, pp. : 1613-1615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience

By Nishikawa Hiroki Tsudo Mitsuru Osaki Yukio

Oncology Reports, Vol. 28, Iss. 3, 2012-09 ,pp. : 835-840

Spandidos Publications

Access to resources Recommend Favorite

Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis

By Derk C.T. Conway R.T. Jimenez S.A.

Oral Oncology, Vol. 40, Iss. 1, 2004-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

T-Cell-Rich B-Cell Lymphoma and Epstein-Barr Virus Infection of the Uterus in a Postmenopausal Patient with an Intrauterine Contraceptive Device in Place for over 20 Years

By Gutman P.D. Williams J.P. Dveksler G.S. Hoffmeister K. Cotelingam J.D.

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 288-292

Elsevier

Access to resources Recommend Favorite

Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2307-2312

Spandidos Publications

Access to resources Recommend Favorite

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite